Wednesday, June 24, 2020

HEALTH-TIMES: 'First-in-class' precision cancer drug shows promising results in Phase I trial


"'First-in-class' precision cancer drug shows promising results in Phase I trial" A new drug targeting cancer’s ability to repair its DNA has shown promising results in a Phase I trial. 
Previous Post
Next Post

0 comments:

If you have any doubt , please let me know about it
And if you want information about a new topic then you can comment your suggestions.